Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
RASH
MCID: EXN002
MIFTS: 58

Exanthem (RASH)

Categories: Infectious diseases, Skin diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Exanthem

About this section

MalaCards integrated aliases for Exanthem:

Name: Exanthem 12 15 17
Exanthema 12 43
Rash 12 15
Rashes 42

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Skin diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:0050486
ICD9CM 34 782.1
MeSH 43 D005076
SNOMED-CT 67 1806006
ICD10 32 R21
UMLS 71 C0015230
Sources

Summaries for Exanthem

About this section
MedlinePlus : 42 A rash is an area of irritated or swollen skin. Many rashes are itchy, red, painful, and irritated. Some rashes can also lead to blisters or patches of raw skin. Rashes are a symptom of many different medical problems. Other causes include irritating substances and allergies. Certain genes can make people more likely to get rashes. Contact dermatitis is a common type of rash. It causes redness, itching, and sometimes small bumps. You get the rash where you have touched an irritant, such as a chemical, or something you are allergic to, like poison ivy. Some rashes develop right away. Others form over several days. Although most rashes clear up fairly quickly, others are long-lasting and need long-term treatment. Because rashes can be caused by many different things, it's important to figure out what kind you have before you treat it. If it is a bad rash, if it does not go away, or if you have other symptoms, you should see your health care provider. Treatments may include moisturizers, lotions, baths, cortisone creams that relieve swelling, and antihistamines, which relieve itching.

MalaCards based summary : Exanthem, also known as exanthema, is related to wissler's syndrome and measles. An important gene associated with Exanthem is CCR6 (C-C Motif Chemokine Receptor 6), and among its related pathways/superpathways are ERK Signaling and PEDF Induced Signaling. The drugs Morphine and Vancomycin have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and breast, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A skin disease that is characterized by a rash that results from a variety of causes including bacteria, viruses, toxins, drugs and autoimmune disorders.

Wikipedia : 74 An exanthem is a widespread rash occurring on the outside of the body and usually occurring in children.... more...

Sources

Related Diseases for Exanthem

About this section

Diseases in the Exanthem family:

Bacterial Exanthem Viral Exanthem

Diseases related to Exanthem via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 985)
# Related Disease Score Top Affiliating Genes
1 wissler's syndrome 33.0 TNFRSF1B IL1RN CRP CD4
2 measles 31.7 TNF IL6 IL2 CD40LG
3 urticaria 31.4 TNF IL6 CRP CD40LG
4 drug reaction with eosinophilia and systemic symptoms 31.4 TNF CRP
5 purpura 31.4 TNF IL6 CRP CD40LG
6 rubella 31.3 TNFRSF1B TNF IL6 IL2 GPT CD40LG
7 contact dermatitis 31.3 TNF IL6 IL2 CD4
8 dermatitis 31.3 TNF IL6 IL2 CTLA4 CCR6
9 erythema multiforme 31.3 TNF IL6 IL2
10 mouth disease 31.3 IL6 ICOSLG H2AC18 CRP CCR6
11 meningitis 31.3 TNF IL6 IL2 CRP CD40LG ALB
12 secondary syphilis 31.3 CD8A CD40LG CD4
13 aseptic meningitis 31.2 TNF IL1RN CD40LG
14 mumps 31.2 TNFRSF1B TNF IL6 IL2 CD40LG
15 scarlet fever 31.2 TNF CRP CD40LG ALB
16 allergic hypersensitivity disease 31.2 TNF IL2 ICOSLG H2AC18 CTLA4 CD4
17 african tick-bite fever 31.2 TNF IL6 GPT CD40LG
18 epidemic typhus 31.1 GPT CRP CD8A CD40LG CD4
19 chickenpox 31.1 TNFRSF1B TNF IL6 IL2 ICOSLG CRP
20 vasculitis 31.1 TNFRSF1B TNF IL6 CTLA4 CRP CD40LG
21 kawasaki disease 31.1 TNF IL6 GPT CRP CD40LG CD4
22 poliomyelitis 31.0 TNF CD8A CD40LG CD4
23 spotted fever 31.0 TNF CTLA4 CD40LG
24 stomatitis 31.0 TNF IL6 IL2 IL1RN CD40LG CD4
25 lymphadenitis 31.0 TNF ICOSLG CRP CD4 CCR6
26 guillain-barre syndrome 31.0 TNFRSF1B TNF CD40LG ALB
27 smallpox 31.0 TNF IL2 IL1RN
28 coccidioidomycosis 31.0 CD40LG CD4 CCR6
29 syphilis 31.0 GPT CRP CD8A CD40LG CD4 CCR6
30 spongiotic dermatitis 30.9 CD8A CD4 CCR6
31 cat-scratch disease 30.9 CRP CD40LG CD4
32 neutropenia 30.9 IL6 IL1RN GPT CYP3A4 CRP
33 allergic contact dermatitis 30.9 TNF IL6 CD4
34 monkeypox 30.9 CD8A CD40LG CD4
35 drug allergy 30.9 GPT CYP3A4 CRP CD40LG CD4 ALB
36 thrombocytopenic purpura, autoimmune 30.9 ICOSLG CD40LG CD4 CCR6
37 parotitis 30.8 CRP CD40LG CD4 ALB
38 streptococcal toxic-shock syndrome 30.8 TNF IL6 IL2
39 vaccinia 30.8 TNF IL6 IL2 CTLA4
40 pleural empyema 30.8 CRP CD40LG CD4 ALB
41 erysipelas 30.8 TNF IL6 IL2 IL1RN CRP CD40LG
42 interstitial nephritis 30.8 ICOSLG CRP CD40LG ALB
43 pustulosis of palm and sole 30.8 TNFRSF1B TNF IL1RN CCR6
44 cervical adenitis 30.8 IL1RN CRP CD40LG
45 cutaneous lupus erythematosus 30.8 TNF IL6 CD40LG
46 pustulosis palmaris et plantaris 30.8 TNF CD40LG CCR6
47 lyme disease 30.8 TNF IL6 CRP CD40LG
48 uveitis 30.8 TNFRSF1B TNF IL6 IL2 CTLA4
49 schnitzler syndrome 30.8 IL1RN CRP CD40LG
50 endocarditis 30.8 TNFRSF1B TNF IL6 CRP ALB

Graphical network of the top 20 diseases related to Exanthem:



Diseases related to Exanthem
Sources

Symptoms & Phenotypes for Exanthem

About this section

MGI Mouse Phenotypes related to Exanthem:

45 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.34 ALB CCR6 CD40LG CRP CTLA4 EGFR
2 homeostasis/metabolism MP:0005376 10.31 ALB CCR6 CD274 CD4 CD40LG CRP
3 cellular MP:0005384 10.29 ALB CD274 CD4 CD40LG CD8A EGFR
4 endocrine/exocrine gland MP:0005379 10.26 ALB CD4 CD40LG CD8A CTLA4 EGFR
5 immune system MP:0005387 10.25 ALB CCR6 CD274 CD4 CD40LG CD8A
6 hematopoietic system MP:0005397 10.23 CCR6 CD274 CD4 CD40LG CD8A CTLA4
7 digestive/alimentary MP:0005381 10.19 ALB CD4 CTLA4 EGFR ERBB2 HRAS
8 mortality/aging MP:0010768 10.17 ALB CD274 CD4 CD40LG CD8A CTLA4
9 integument MP:0010771 10.15 CD274 CD4 CD40LG CD8A CTLA4 EGFR
10 neoplasm MP:0002006 9.86 ALB EGFR ERBB2 HRAS IL2 IL6
11 normal MP:0002873 9.81 ALB CCR6 CD4 CD8A CTLA4 EGFR
12 respiratory system MP:0005388 9.56 CTLA4 EGFR ERBB2 HRAS IL2 IL6
13 skeleton MP:0005390 9.36 CD274 CD40LG CTLA4 EGFR ERBB2 GPT
Sources

Drugs & Therapeutics for Exanthem

About this section

Drugs for Exanthem (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 713)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Morphine Approved, Investigational Phase 4 57-27-2 5288826
2
Vancomycin Approved Phase 4 1404-90-6 441141 14969
3
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
4
Enalaprilat Approved Phase 4 76420-72-9 6917719
5
Ceftaroline fosamil Approved, Investigational Phase 4 229016-73-3
6
Cefazolin Approved Phase 4 25953-19-9 33255 656510
7
Efavirenz Approved, Investigational Phase 4 154598-52-4 64139
8
Nevirapine Approved Phase 4 129618-40-2 4463
9
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
10
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
11
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
12
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
13
Sulfadiazine Approved, Investigational, Vet_approved Phase 4 68-35-9 5215
14
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
15
Polyestradiol phosphate Approved Phase 4 28014-46-2
16
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
17
Cefpirome Approved Phase 4 84957-29-9 5479539
18
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
19
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
20
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
21
Amifostine Approved, Investigational Phase 4 20537-88-6 2141
22
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
23
Bezafibrate Approved, Investigational Phase 4 41859-67-0 39042
24
Methyltestosterone Approved Phase 4 58-18-4 6010
25
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
26
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 6013 10204
27
Testosterone enanthate Approved Phase 4 315-37-7 9416
28
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
29
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
30
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
31
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
32
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
33
Ledipasvir Approved Phase 4 1256388-51-8 67505836
34
Cocaine Approved, Illicit Phase 4 50-36-2 5760 446220
35
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
36
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
37
Topiramate Approved Phase 4 97240-79-4 5284627
38
Sulfamethoxazole Approved Phase 4 723-46-6 5329
39
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
40
Azithromycin Approved Phase 4 83905-01-5 447043 55185
41
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
42
Rifampicin Approved Phase 4 13292-46-1 5381226 5458213
43
Amantadine Approved Phase 4 768-94-5 2130
44
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
45
Clarithromycin Approved Phase 4 81103-11-9 84029
46
Dexlansoprazole Approved, Investigational Phase 4 138530-94-6, 103577-45-3 9578005
47
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
48
Fenofibrate Approved Phase 4 49562-28-9 3339
49
Maraviroc Approved, Investigational Phase 4 376348-65-1 3002977
50
Praziquantel Approved, Investigational, Vet_approved Phase 4 55268-74-1 4891

Interventional clinical trials:

(show top 50) (show all 753)
# Name Status NCT ID Phase Drugs
1 Non-randomized Phase-IV-study to Investigate the Efficacy of FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema Unknown status NCT01315990 Phase 4 FOLFIRI + Cetuximab
2 Randomized Controlled Trial Comparing the Efficacy and Safety of Calmoseptine Ointment and Desitin Maximum Strength 40% Zinc Oxide Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Unknown status NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
3 Evaluation of Effectiveness and Safety of Oral Vancomycin in Treatment of Primary Sclerosing Cholangitis. Unknown status NCT02605213 Phase 4 Vancomycin;Placebo
4 Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® Unknown status NCT01553032 Phase 4 Erbitux®
5 Evaluation Whether Higher Retention Rate is in Those of Combined Methadone With N-Acetyl-Cysteine Compared to Those With Methadone Alone During a Six-month Study Unknown status NCT01047956 Phase 4 Methadone; NAC;Methadone
6 A Clinical Study on Anti-Hypertensive Agent (ACEi) and Heart Function Improvement Unknown status NCT01069042 Phase 4 Enalapril
7 An Open-Label Pilot Study to Compare the Efficacy of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids Unknown status NCT01583478 Phase 4
8 Comparison of Efficacy and Safety of the Postoperative Analgesia Methods for Supratentorial Craniotomy by Integrated Pulmonary Index (IPI) Unknown status NCT02929147 Phase 4 Morphine;Dexketoprofen;Placebo
9 IDC 56: A Randomized Double-blinded Study Comparing Ceftaroline to Standard of Care Therapy With Cefazolin and Vancomycin as Surgical Prophylaxis for High Risk Orthopedic and Cardiac Surgeries Unknown status NCT02307006 Phase 4 Ceftaroline;Cefazolin / Vancomycin
10 ASSESSMENT OF GH-IGF1 AXIS AND TO STUDY RESPONSE TO GH THERAPY IN CHILDREN WITH CML IN REMISSION HAVING GH DEFICIENCY Unknown status NCT01901666 Phase 4 Growth Hormone
11 Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Completed NCT00280514 Phase 4 cefpirome and moxifloxacin administration
12 A Parallel, Evaluator-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Two Marketed Topical Skin Protectants Containing Zinc Oxide in Children With Diaper Rash Completed NCT00219466 Phase 4
13 A Multicenter, Randomized, Open-label, Controlled Study of Nevirapine (VIRAMUNE®) and a Short Course of Prednisone to Determine the Safety and Effectiveness of This Strategy in Preventing Nevirapine (VIRAMUNE®) Associated Rash. Completed NCT02184299 Phase 4 Nevirapine;Prednisone
14 A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Completed NCT02152800 Phase 4 valacyclovir hydrocholoride
15 Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities Completed NCT00158041 Phase 4 Amifostine administered subcutaneously
16 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavaxâ„¢ Completed NCT02958345 Phase 4
17 Prospective 2-Year Longitudinal Study to Assess for Miconazole Resistance in Candida Spp. With Repeated Treatment Courses of 0.25% Miconazole Nitrate Ointment in Neonates and Infants up to 1 Year of Age With Recurrent Moderate-Severe Diaper Dermatitis Complicated by Cutaneous Candidiasis Completed NCT00702507 Phase 4 0.25 % Miconazole Nitrate Ointment
18 Early Effect Of Bezafibrate On Fibrinogen Levels, Inflammatory Response And Clinical Impact, In Patients With ST Elevation Acute Myocardial Infarction Completed NCT02291796 Phase 4 Bezafibrate
19 Physiologic Testosterone Replacement in Women With Hypopituitarism Completed NCT00144391 Phase 4 Transdermal Testosterone gel
20 Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia Completed NCT00885586 Phase 4 gabapentine
21 Aloe Vera and Chlorhexidine as Preventive Oral Antiseptics Against the Appearance of Traumatic Oral Ulcers in Patients With Fixed Orthodontics: a Randomized Clinical Trial Completed NCT03633292 Phase 4 Antiseptic clorhexidine gel (Lacer, Barcelona, Spain);Master formula of aloe vera gel 80%
22 A Multi-center, Double-blinded Randomized Trial for Genotype Based Personalized Prescription of Nevirapine Completed NCT00986063 Phase 4
23 Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome Completed NCT02961998 Phase 4 Celecoxib;Sorafenib
24 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS) Completed NCT00200941 Phase 4 Topiramate
25 Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients: A Randomized Controlled Trial. Completed NCT00367081 Phase 4 TMX-SMX (Bactrim(R));Pyrimethamine plus Sulfadiazine plus leucoverin
26 The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment Completed NCT01318356 Phase 4 Doxycycline;Placebo
27 A Retrospective Study to Compare the 3-Year Antiviral Efficacy of Nevirapine and Efavirenz in Combination With D4t and 3tc in 2NN Patients and of Trizivir Versus Trizivir Plus Nevirapine in CHARM Patients Completed NCT00127972 Phase 4 stavudine;lamivudine;nevirapine;efavirenz;trizivir
28 Comparison of Nevirapine Levels With and Without Dose Escalation in HIV-infected Patients Commencing Antiretroviral Therapy Who Are Also Receiving Rifampicin Based Anti-tuberculous Therapy Completed NCT00617643 Phase 4 Nevirapine without dose escalation;Nevirapine initiation with dose escalation
29 A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain: A Randomized Control Trial Completed NCT03221946 Phase 4 Diclofenac Sodium;Diclofenac sodium;Diclofenac
30 The Immunologic Effects of HCV Therapy With Fixed Dose Combination Ledipasvir/Sofosbuvir (HARVONI) in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs. Completed NCT02347345 Phase 4 Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
31 Proteomic Profiling for Influenza Vaccination Completed NCT00133588 Phase 4
32 Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases Completed NCT02040116 Phase 4 Rituximab Infusion
33 A Randomized, Double-blind, Placebo-controlled, Trial of Lamotrigine add-on Therapy in Outpatients With Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence Completed NCT00280293 Phase 4 Lamotrigine;Placebo
34 A Prospective, Randomized, Placebo-controlled Trial of Pre-transplant and Prompt Post-transplant Treatment With Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation Completed NCT01915082 Phase 4 Azithromycin;Ora-Plus
35 The Effect of Amantadine on Movement Disorder in Ataxia-Telangiectasia Completed NCT00950196 Phase 4 amantadine sulphate
36 A Comparison of Bupropion SR and Placebo for Smoking Cessation Completed NCT00176449 Phase 4 Bupropion SR;Placebo Oral Tablet
37 A Double Blinded Randomized Controlled Trial to Compare the Efficacy, Time to Onset, and Duration of Two Botulinum Type A Exotoxins (Onabotulinum Toxin A and Abobotulinum Toxin A) in the Treatment of "Crow's Feet." Completed NCT01529788 Phase 4 Right lateral orbital injection of Botox Cosmetic or Dysport;Left lateral orbital injection of Botox Cosmetic or Dysport
38 Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment Completed NCT00816140 Phase 4 Cravit based triple therapy;Klaricid based triple therapy
39 Efficacy and Safety of Extended Release Niacin-Fenofibrate Combination and Monotherapy for the Treatment of Atherogenic Dyslipidemia in Obese Females Completed NCT03615534 Phase 4 Fenofibrate
40 Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Highly Endemic Areas of Northeastern Brazil Completed NCT00403611 Phase 4 Praziquantel 60 mg/kg;Praziquantel 40 mg/kg
41 A Prospective, Randomized, Double Blind Study Comparing the Efficacy and Safety of Fentanyl Nasal Spray to Placebo as an Analgesic, in Patients Undergoing Outpatient Cystoscopic Procedures Completed NCT01708122 Phase 4 Fentanyl;saline
42 A Trial of Evaluating Additional Benefit of Cilostazol to Dual Antiplatelet Therapy in Patients With Long or Multi-vessel Coronary Artery Disease Underwent Biolimus-Eluting Stent Implantation Completed NCT01192724 Phase 4 Cilostazol;Aspirin;Clopidogrel
43 A Pilot Evaluation of the Pharmacokinetics, Efficacy and Safety of Switching From Efavirenz to Maraviroc Administered at 600mg Then 300mg Twice-daily in Patients Suppressed on an Efavirenz-containing Regimen as Initial Therapy Completed NCT01190293 Phase 4 Maraviroc
44 Evaluation of Ureteral Patency in the Post-indigo Carmine Era Completed NCT02677623 Phase 4 Pyridium;Sodium Fluorescein;Mannitol
45 Phenytoin as an Augmentation for SSRI Failures: A Controlled Study Completed NCT00146237 Phase 4 phenytoin
46 Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication Completed NCT03650543 Phase 4 amoxicillin clarithromycin omeprazole 1;amoxicillin clarithromycin omeprazole 2
47 Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life Completed NCT02258763 Phase 4 Amoxicillin-Potassium Clavulanate Combination;Placebo
48 A Study of Sertraline to Prevent PTSD Completed NCT00182078 Phase 4 Placebo;Sertraline
49 EFFICACY OF KETAMINE-PROPOFOL COMBINATION FOR SHORT SURGICAL PROCEDURES Completed NCT01651988 Phase 4 Ketamina-Propofol Combination
50 Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial Completed NCT03052998 Phase 4 Ivermectin

Search NIH Clinical Center for Exanthem

Cochrane evidence based reviews: exanthema

Sources

Genetic Tests for Exanthem

About this section
Sources

Anatomical Context for Exanthem

About this section

MalaCards organs/tissues related to Exanthem:

40
Skin, Lung, Breast, Testes, Liver, T Cells, Bone
Sources

Publications for Exanthem

About this section

Articles related to Exanthem:

(show top 50) (show all 25648)
# Title Authors PMID Year
1
Atopic Dermatitis in Adults. 42
31757234 2020
2
Allergic Contact Dermatitis. 42
31757238 2020
3
Efficacy of Topical Botanical Treatment of Children With Mild to Moderate Atopic Dermatitis 42
31584783 2019
4
Relations among motives, negative urgency, and mindfulness skills in college drinkers. 61
31645001 2020
5
A mysterious rash around surgical wounds. 61
31520773 2020
6
Metagenomic next-generation sequencing helped diagnose scrub typhus without eschar: A case report. 61
31648003 2020
7
Graft-versus-host disease after living donor liver transplantation: an unpredictable troublesome complication for liver transplant centers. 61
31524772 2020
8
Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018. 61
31463940 2020
9
Sudden-onset Fever and Rash in a 9-year-old Girl. 61
31815843 2020
10
A rickettsia infection from Saudi Arabia. 61
31689527 2020
11
Severe Acute Kidney Injury Due to Nivolumab/Ipilimumab-induced Granulomatosis and Fibrinoid Vascular Necrosis. 61
31567702 2020
12
Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer. 61
31566114 2020
13
Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting. 61
30832554 2020
14
Pediatric Toxic Shock Syndrome After a 7% Burn: A Case Study and Systematic Literature Review. 61
31192868 2020
15
Risk of Hypersensitivity Reactions to Iopromide After Intra-Arterial Versus Intravenous Administration: A Nested Case-Control Analysis of 133,331 Patients. 61
31524764 2020
16
The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck. 61
31586664 2020
17
Strange rash after travel to Thailand. 61
30342754 2019
18
Papulopustular Rash Due to Tocilizumab. 61
31462590 2019
19
Measles outbreak from Hong Kong International Airport to the hospital due to secondary vaccine failure in healthcare workers. 61
31587686 2019
20
Rash on the Ankle. 61
31845778 2019
21
Desquamating pustular rash. 61
31821140 2019
22
Neutropenic Fever and a Diffuse Hyperpigmented Papular Rash: Answer. 61
31764234 2019
23
Case 2: A Newborn with a Changing Rash. 61
31792161 2019
24
Dengue rash: white islands in a sea of red. 61
31422377 2019
25
Neutropenic Fever and a Diffuse Hyperpigmented Papular Rash: Challenge. 61
30398987 2019
26
A 60-Year-Old Man With Right Lung Mass Presents With Cough. 61
31812213 2019
27
Identifying Children With Measles for Isolation in a High-volume Pediatric Emergency Department in Singapore. 61
31738335 2019
28
Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors. 61
31820255 2019
29
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function. 61
31601675 2019
30
Heightened Immune Response to Presumed Loxosceles reclusa Envenomation. 61
31685322 2019
31
Atypical acral swelling and viral exanthem with parechovirus meningitis. 61
31833105 2019
32
Combination trial of duvelisib (IPI-145) with rituximab or bendamustine/rituximab in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia. 61
31490009 2019
33
Sex differences in clinical presentation of systemic lupus erythematosus. 61
31843005 2019
34
PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus. 61
31180450 2019
35
Clinical characteristics and survival of 413 patients with systemic lupus erythematosus in southeastern areas of South Korea: A multicenter retrospective cohort study. 61
31802639 2019
36
Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis. 61
31779485 2019
37
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. 61
31852579 2019
38
A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment. 61
31746725 2019
39
Clinical and epidemiologic characteristics associated with dengue during and outside the 2016 outbreak identified in health facility-based surveillance in Ouagadougou, Burkina Faso. 61
31809504 2019
40
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome. 61
31366601 2019
41
Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center. 61
31190585 2019
42
Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: a propensity score-matched multi-institutional cohort study. 61
31046497 2019
43
Black Mamba Death: Venom Versus Antivenom? 61
31318708 2019
44
Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study. 61
31648099 2019
45
Asymptomatic Rash in a Male Infant with Incontinentia Pigmenti. 61
31383470 2019
46
Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia. 61
30514174 2019
47
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. 61
31841354 2019
48
Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired Pneumonia. 61
31851288 2019
49
Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts. 61
31829244 2019
50
Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention. 61
31668189 2019
Sources

Variations for Exanthem

About this section
Sources

Expression for Exanthem

About this section
Search GEO for disease gene expression data for Exanthem.
Sources

Pathways for Exanthem

About this section

Pathways related to Exanthem according to GeneCards Suite gene sharing:

(show top 50) (show all 63)
# Super pathways Score Top Affiliating Genes
1
ERK Signaling 63
Show member pathways
 13.86 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
2
PEDF Induced Signaling 63
Show member pathways
 13.66 TNFRSF1B TNF IL6 IL2 IL1RN HRAS
3
Innate Immune System 65
Show member pathways
 13.65 TNFRSF1B TNF IL6 IL2 IL1RN ICOSLG
4
Class I MHC mediated antigen processing and presentation 65
Show member pathways
 13.47 ICOSLG HRAS ERBB2 EGFR CTLA4 CD8A
5
Akt Signaling 63
Show member pathways
 13.37 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
6
Cytokine Signaling in Immune system 65
Show member pathways
 13.3 TNFRSF1B TNF IL6 IL2 IL1RN HRAS
7
PAK Pathway 63
Show member pathways
 13.2 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
8
PI3K-Akt signaling pathway 36
Show member pathways
 13.03 TNF IL6 IL2 HRAS ERBB2 EGFR
9
TNFR1 Pathway 63
Show member pathways
 12.98 TNFRSF1B TNF IL6 HRAS EGFR CD4
10
Human cytomegalovirus infection 36
Show member pathways
 12.97 TNFRSF1B TNF IL6 HRAS EGFR CD4
11
Common Cytokine Receptor Gamma-Chain Family Signaling Pathways 64
Show member pathways
 12.81 TNFRSF1B TNF IL6 IL2 HRAS
12
NF-KappaB Family Pathway 63
Show member pathways
 12.73 TNFRSF1B TNF IL6 IL2 EGFR CD40LG
13
4-1BB Pathway 63
Show member pathways
 12.67 TNFRSF1B TNF HRAS EGFR CD40LG CD4
14
Allograft rejection 36 1
Show member pathways
 12.66 TNF IL6 IL2 ICOSLG CTLA4 CD8A
15
Immune response NFAT in immune response 22
Show member pathways
 12.61 TNFRSF1B TNF IL2 ICOSLG HRAS CD40LG
16
mTOR signaling pathway (KEGG) 36
Show member pathways
 12.54 TNFRSF1B TNF HRAS ERBB2 EGFR
17
Immune response IL-23 signaling pathway 22
Show member pathways
 12.53 TNF IL6 IL2 HRAS ERBB2 EGFR
18
ICos-ICosL Pathway in T-Helper Cell 63
Show member pathways
 12.42 IL2 ICOSLG CTLA4 CD40LG